Stock ZYDUSLIFE ZYDUS LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Market Closed - NSE India S.E.
Other stock markets
 03:17:43 2024-05-18 am EDT 		5-day change 1st Jan Change
1,104 INR +5.00% Intraday chart for Zydus Lifesciences Limited +11.23% +60.18%
May. 20 Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold MT
May. 17 Transcript : Zydus Lifesciences Limited, Q4 2024 Earnings Call, May 17, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold
MT
Transcript : Zydus Lifesciences Limited, Q4 2024 Earnings Call, May 17, 2024
Zydus Lifesciences Limited Proposes Final Dividend for the Financial Year Ended on March 31, 2024, Payable on or After August 13, 2024
CI
Zydus Lifesciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Zydus Lifesciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets
MT
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
RE
Zydus Lifesciences Limited Announces Completion of Enrolment for EPICS IIITM Phase 2B/3 Trial Evaluating Saroglitazar Mg in Treatment of Primary Biliary Cholangitis
CI
Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel
MT
Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5%
CI
Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
AQ
Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug
MT
Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19
CI
Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19
CI
Weak March Quarter Earnings Weigh Down Indian Equities on Friday
MT
Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream
MT
Zydus Lifesciences Limited Receives Final Approval from USFDA for Tretinoin Cream USP, 0.1%
CI
Zydus Lifesciences Limited Receives Demand Order-In-Original for the Financial Year 2018-19
CI
Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection
MT
China Medical System's Anti-Anaemia NDA Accepted in China
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. News Zydus Lifesciences Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW